147 related articles for article (PubMed ID: 27805602)
21. Ultraearly assessed reperfusion status after middle cerebral artery recanalization predicting clinical outcome.
Gölitz P; Muehlen I; Gerner ST; Knossalla F; Doerfler A
Acta Neurol Scand; 2018 Jun; 137(6):609-617. PubMed ID: 29424118
[TBL] [Abstract][Full Text] [Related]
22. MRI Guiding of the Middle Cerebral Artery Occlusion in Rats Aimed to Improve Stroke Modeling.
Gubskiy IL; Namestnikova DD; Cherkashova EA; Chekhonin VP; Baklaushev VP; Gubsky LV; Yarygin KN
Transl Stroke Res; 2018 Aug; 9(4):417-425. PubMed ID: 29178027
[TBL] [Abstract][Full Text] [Related]
23. A review of experimental models of focal cerebral ischemia focusing on the middle cerebral artery occlusion model.
Trotman-Lucas M; Gibson CL
F1000Res; 2021; 10():242. PubMed ID: 34046164
[TBL] [Abstract][Full Text] [Related]
24. Blocking pterygopalatine arterial blood flow decreases infarct volume variability in a mouse model of intraluminal suture middle cerebral artery occlusion.
Chen Y; Ito A; Takai K; Saito N
J Neurosci Methods; 2008 Sep; 174(1):18-24. PubMed ID: 18640153
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
Yu S; Liu X; Shen Y; Xu H; Yang Y; Ding F
Neuroscience; 2016 Jul; 327():44-52. PubMed ID: 27060484
[TBL] [Abstract][Full Text] [Related]
26. Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.
Nakano T; Irie K; Hayakawa K; Sano K; Nakamura Y; Tanaka M; Yamashita Y; Satho T; Fujioka M; Muroi C; Matsuo K; Ishikura H; Futagami K; Mishima K
Brain Res; 2015 Oct; 1624():330-335. PubMed ID: 26254727
[TBL] [Abstract][Full Text] [Related]
27. Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass.
Kelly ME; Furlan AJ; Fiorella D
Stroke; 2008 Jun; 39(6):1770-3. PubMed ID: 18388338
[TBL] [Abstract][Full Text] [Related]
28. Animal Stroke Model: Ischemia-Reperfusion and Intracerebral Hemorrhage.
Ren C; Sy C; Gao J; Ding Y; Ji X
Methods Mol Biol; 2016; 1462():373-90. PubMed ID: 27604729
[TBL] [Abstract][Full Text] [Related]
29. Consistent focal cerebral ischemia without posterior cerebral artery occlusion and its real-time monitoring in an intraluminal suture model in mice.
Akamatsu Y; Shimizu H; Saito A; Fujimura M; Tominaga T
J Neurosurg; 2012 Mar; 116(3):657-64. PubMed ID: 22196098
[TBL] [Abstract][Full Text] [Related]
30. Focal cerebral ischemia.
Braeuninger S; Kleinschnitz C; Nieswandt B; Stoll G
Methods Mol Biol; 2012; 788():29-42. PubMed ID: 22130698
[TBL] [Abstract][Full Text] [Related]
31. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
[TBL] [Abstract][Full Text] [Related]
32. Investigating the mechanisms of perioperative ischemic stroke in the Carotid Occlusion Surgery Study.
Reynolds MR; Grubb RL; Clarke WR; Powers WJ; Zipfel GJ; Adams HP; Derdeyn CP;
J Neurosurg; 2013 Oct; 119(4):988-95. PubMed ID: 23909253
[TBL] [Abstract][Full Text] [Related]
33. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
34. Cerebral Hyperperfusion Syndrome After Endovascular Reperfusion Therapy in a Patient with Acute Internal Carotid Artery and Middle Cerebral Artery Occlusions.
Hashimoto T; Matsumoto S; Ando M; Chihara H; Tsujimoto A; Hatano T
World Neurosurg; 2018 Feb; 110():145-151. PubMed ID: 29146434
[TBL] [Abstract][Full Text] [Related]
35. Impact of time to endovascular reperfusion on outcome differs according to the involvement of the proximal MCA territory.
Hedderich DM; Boeckh-Behrens T; Friedrich B; Wiestler B; Wunderlich S; Zimmer C; Fischer U; Kleine JF; Kaesmacher J
J Neurointerv Surg; 2018 Jun; 10(6):530-536. PubMed ID: 28855346
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Early Superficial Temporal Artery-Middle Cerebral Artery Double Anastomoses for Atherosclerotic Occlusion in Patients with Progressing Stroke.
Inoue A; Kohno K; Iwata S; Ohue S; Ozaki S; Ninomiya S; Tomita H; Kamogawa K; Okamoto K; Fukumoto S; Ichikawa H; Onoue S; Nakamura Y; Okuda B
J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):741-748. PubMed ID: 27816279
[TBL] [Abstract][Full Text] [Related]
37. Rat Model of Middle Cerebral Artery Occlusion.
Raza SS
Methods Mol Biol; 2024; 2761():623-633. PubMed ID: 38427265
[TBL] [Abstract][Full Text] [Related]
38. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes.
Molina CA; Montaner J; Arenillas JF; Ribo M; Rubiera M; Alvarez-Sabín J
Stroke; 2004 Feb; 35(2):486-90. PubMed ID: 14707233
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of a new modified intraluminal suture for temporary middle cerebral artery occlusion in rats of various weight.
Lourbopoulos A; Karacostas D; Artemis N; Milonas I; Grigoriadis N
J Neurosci Methods; 2008 Aug; 173(2):225-34. PubMed ID: 18634824
[TBL] [Abstract][Full Text] [Related]
40. Optimization of behavioural tests for the prediction of outcomes in mouse models of focal middle cerebral artery occlusion.
Wen Z; Xu X; Xu L; Yang L; Xu X; Zhu J; Wu L; Jiang Y; Liu X
Brain Res; 2017 Jun; 1665():88-94. PubMed ID: 28435084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
